It’s been another busy and exciting year here at BioInformatics, now part of Science and Medicine Group. Together with our sister brands, Instrument Business Outlook, IMV Medical Information, Kalorama Information and Strategic Directions International, we’ve been helping clients achieve success through our quantitative and qualitative custom research services, our market research reports and industry data […]
Yesterday we announced that the 2018 SDi Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry will be released in conjunction with PITTCON, which will take place from February 26 – March 1, 2018. It made me think about what an interesting year it’s been for the life science and analytical instrument market […]
Rarely in the scientific realm does a niche technique explode into a viable market worth billions of dollars over just a handful of years. When it does, the chaos that ensues is driven by the scrambling of life science product and service providers who vie with each other to secure market share. The market for […]
Laboratories around the world are adopting the CRISPR/Cas9 genome editing technique for their research. Whether to engineer better cell lines for drug development or repair mutations that cause genetic diseases, researchers have only begun to tap into the tremendous potential that CRISPR/Cas9 promises. Consequently, the genome editing market, of which CRISPR/Cas9 already accounts for more […]
In our most recent report we explore the market for Clustered Regularly Interspaced Short Palindromic Repeats, or more popularly “CRISPR”, is a simple yet powerful genome editing technique that has recently taken the scientific community by storm. When coupled with the Cas9 protein, the technology allows for specific changes (addition, modification and deletions) to be […]
Lab Budgets and Sources of Funding in 2017: The Market Outlook for the United States, Europe and Asia is the latest report from BioInformatics LLC. The report is based on a survey of more than 1,000 life scientists who answered a detailed questionnaire about their budget and spending plans for 2017. Suppliers of laboratory instrumentation […]
BioInformatics has announced three significant upgrades to the Interactive Market Intelligence experience. In addition to much better on-site performance and faster page loading speeds, we have added Net Promoter Score and a Content section, which contains a summarized export and full questionnaire of the report. IMI, launched this year, has transformed the way life science market data […]
We recently conducted an in-depth survey of more than 500 scientists currently using, or planning to adopt, the remarkable technology CRISPR/Cas9. Based on user-submitted budget data and our estimate of the incidence in which CRISPR/Cas 9 is currently used in labs, we estimate the market for CRISPR/Cas9 genome editing products is $200 million. And the […]
This week we’ll be releasing the results of our survey of over 600 Scientists currently using, or planning to adopt, CRISPR/Cas9 on their research. Since the advent of molecular biology technology in the 1970s, there has been steady progress in the ability to alter, or edit, gene sequences at the genomic level. The recent development […]
We’re just a few weeks away from publishing our report on the fast growing market for CRISPR/Cas9 products. In the meantime, we’ve also been engaging with scientists on the ethical questions surround this exciting technology. Before the recent announcement from China that CRISPR had been used to modify human embryos, a slight majority favored such […]
